Autoreactivity of Broadly Neutralizing Influenza Human Antibodies to Human Tissues and Human Proteins

Broadly neutralizing monoclonal antibodies (bNAbs) against conserved domains in the influenza hemagglutinin are in clinical trials. Several next generation influenza vaccines designed to elicit such bNAbs are also in clinical development. One of the common features of the isolated bNAbs is the use o...

Descripción completa

Detalles Bibliográficos
Autores principales: Khurana, Surender, Hahn, Megan, Klenow, Laura, Golding, Hana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600923/
https://www.ncbi.nlm.nih.gov/pubmed/33049994
http://dx.doi.org/10.3390/v12101140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600923/
https://www.ncbi.nlm.nih.gov/pubmed/33049994
http://dx.doi.org/10.3390/v12101140

Ejemplares similares